Takaisin

Safety and effects of supervised exercise on physical function, disease activity, pain and quality of life in people with rheumatoid arthritis

Näytönastekatsaukset
Juho Korpi, Sanna Säteri and Maija Paukkunen
29.10.2026

Level of evidence: B

Exercise is safe and probably improves physical function compared with usual care (health education / active control) in adults with rheumatoid arthritis.

Aerobic exercise probably has a small clinically important benefit on function (mean difference (MD) in HAQ DI −0.25 points; 95% CI −0.38 to −0.11) with no significant difference between long-term and short-term interventions.

There are no major adverse effects reported during exercise interventions, nor does exercise increase the disease activity or pain. On the contrary, evidence indicates that strength exercise may reduce disease activity (DAS28: SMD -0.69 [-1.26, -0.11]; ESR: SMD -0.86 [-1.65, -0.07;] and aerobic exercise may slightly reduce pain compared with other exercise types (SMD −0.46; 95% CI −0.90 to −0.01), but the results are inconclusive. Exercise may result to little or no difference in the quality of life in people with rheumatoid arthritis.

The quality of evidence is downgraded due to overall risk of bias of included studies, imprecision and inconsistency.

The evidence is applicable to adults and elderly people with rheumatoid arthritis.

Table 1. Description of the included studies
Reference Study type Population
n
Country
Intervention (I) and comparison (C) Outcomes (outcome measures) Risk of bias «Additional comments for included studies...»2
Ye
et al. 2022 «Ye H, Weng H, Xu Y, et al. Effectiveness and safet...»1
SR + MA Adults with rheumatoid arthritis
13 RCT studies
967 participants
USA, Netherlands, Turkey, France, Saudi-Arabia, UK, Sweden, Ireland, Mexico
I: Aerobic exercise
C: Usual care or other types of exercise
Function (HAQ DI)
Disease activity
(DAS28 CRP, ESR)
Pain (VAS, SFMPQ)
Moderate
Wen
et al. 2021 «Wen Z, Chai Y. Effectiveness of resistance exercis...»2
SR + MA Adults with rheumatoid arthritis without other serious diseases
17 RCT studies
610 participants
USA, UK, Finland, Sweden, Netherlands, Bosnia, New Zealand, Ireland, Korea
I: Strength + rehabilitation exercise
C: usual care (regular nursing), non-aerobic exercise or range of movement exercise.
Function (HAQ DI)
Disease activity
(DAS28, ESR)
Pain (VAS)
High
Sobue
et al. 2021 «Sobue Y, Kojima T, Ito H, et al. Does exercise the...»3
SR + MA Adults with rheumatoid arthritis
9 RCT studies
1343
participants
I: Exercise therapy
C: Usual care
Function (HAQ)
Disease activity
(VAS, DAS28)
Pain (VAS)
Quality of life (SF-36, EQ-5D)
High
Andonian
et al. 2023 «Andonian BJ, Ross LM, Sudnick AM, et al. Effect of...»4
RCT Physically inactive older adults with rheumatoid arthritis
20 participants
I: Combination exercise (aerobic + strength) + diet
C: Diet and exercise counselling
Disease activity
(DAS28, CRP, ESR)
Low
Cerasola
et al. 2023 «Cerasola D, Argano C, Chiovaro V, et al. Physical ...»5
RCT Adults with rheumatoid arthritis
80 participants
Italy
I: Occupational therapy and home exercise
C: brochure about home exercises and general information
Function (HAQ)
Disease activity (DAS28, CRP, ESR)
Low
Tauwen
et al. 2024 «Teuwen MMH, van Weely SFE, Vliet Vlieland TPM, et ...»6
RCT Adults with rheumatoid arthritis and severe limitations in daily activities
217 participants
Netherlands
I: Combination exercise (aerobic, strength, mobility, functional)
C: Usual care (might include rehabilitation)
Function (PSC1 NRS, PROMIS, HAQ-DI)
Quality of life (RAQoL)
Low
Bilberg
et al. 2024 «Bilberg A, Mannerkorpi K, Borjesson M, et al. High...»7
RCT Adults with stable rheumatoid arthritis and low physical activity
87 participants
Sweden
I: Combination exercise (HIIT + strength)
C: Education on exercise and home exercise program
Disease activity (DAS28, CRP, ESR)
Pain (VAS)
Low
RCT = randomized controlled trial; SR = systematic review; MA = meta-analysis; HAQ = Health Assessment Questionnaire; HAQ DI = Health Assessment Questionnaire disability index; DAS28 = Disease Activity Score in 28 joints; VAS = visual analogue scale; SFMPQ = Short Form McGill Pain Questionnaire; SF-36 = Short-Form Health Survey 36; SF-12 = Short-Form Health Survey 12; PROMIS = Patient-Reported Outcomes Measurement Information System; PSC1 NRS = Patient-Specific Complaints Numerical Rating Scale; RAQoL = Rheumatoid Arthritis Quality of Life Questionnaire; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; HIIT = high-intensity interval training
Table 2. Additional comments for included studies
Reference Comments
Ye
et al. 2022 «Ye H, Weng H, Xu Y, et al. Effectiveness and safet...»1
Interventions: aerobic exercise interventions performed at 50–90% of the maximal heart rate, including walking, cycling, jogging,
etc. Duration of interventions: 2-96 weeks. Meta-analysis subgroups: long term > 16weeks and short term ≤ 16 weeks.
Review lacks an assessment of publication bias. 8/13 of the original studies have high risk of bias due to lack of allocation concealment. No other concerns identified.
Wen
et al. 2021 «Wen Z, Chai Y. Effectiveness of resistance exercis...»2
Exercise interventions were mostly land-based leg and arm strength training, performed 1-3 times/week, 5-75 minutes/ training session. Duration of the interventions varied from 4 to 104 weeks.
Review lacks a pre-registered protocol and sensitivity analysis. The risk of bias assessment is not reported, only total Jadad-scores. Risk of bias in the meta-analysis due to variations in the length of interventions in the same analysis.
Sobue
et al. 2021 «Sobue Y, Kojima T, Ito H, et al. Does exercise the...»3
Intervention: Diverse exercise programs, including dynamic exercise, progressive resistance, water-based aerobic exercise and sensorimotor training. Duration of the interventions: 4-16 weeks.
Review lacks a pre-registered protocol, sensitivity analysis and a clear estimate of publication bias. 2/6 of the original studies have an unclear risk of bias due to allocation concealment and all studies have high risk of bias due to lack of blinding of the outcome assessment.
Andonian
et al. 2023 «Andonian BJ, Ross LM, Sudnick AM, et al. Effect of...»4
Inclusion criteria: adults aged 60 to 80 years with overweight/obesity (body mass index: 28–40), with seropositive or erosive RA meeting 2010 ACR/EULAR criteria for RA,28 not currently meeting the 2018 Physical Activity Guidelines for Americans,29 and without absolute contraindications to exercise were enrolled.
Interventions: aerobic training (150 minutes/week moderate-to-vigorous intensity), resistance training (two days/week), and a hypocaloric diet (7% weight loss goal. Control group completed two lifestyle counseling sessions followed by monthly check-ins. Duration of the interventions: 16 weeks.
Unable to blind participants due to intervention, might have some effect on PROMIS. No other biases detected.
Cerasola
et al. 2023 «Cerasola D, Argano C, Chiovaro V, et al. Physical ...»5
The selection criteria included a diagnosis of rheumatoid arthritis, aged 18 years or older. Patients aged under 18 and subjects with formed deformations of joints that prevent physical exercise or severe anemia were excluded.
Intervention included occupational therapy: (1)physical exercise to manage balance to maintain muscle tone and joint restart after the night, and (2) joint protection and decreased joint load during daily actions. The physical exercise included the flexion and extension of the upper and lower limbs for the main joints (ankle, knee, cox-femoris, elbow, wrist,
and shoulder) with or without weight tools for 20/30 min day. Duration of the intervention: 30 days. No study protocol available. Unable to blind participants due to intervention, might have some effect on HAQ. No other biases detected.
Tauwen
et al. 2024 «Teuwen MMH, van Weely SFE, Vliet Vlieland TPM, et ...»6
Eligible individuals were adults (aged ≥18 years) with a clinical diagnosis of RA made by a rheumatologist. Individuals had self-perceived severe limitations in daily activities involving self-care (eg, dressing, washing), and/or transfers (eg, getting in and out of bed, rising from a chair or using the toilet), and/or mobility indoors or outdoors. Individuals who had received physical therapy in the past 3 months, either or not in the context of a multidisciplinary team intervention or were shortly in need of admission to a hospital or rehabilitation centre, were excluded.
Intervention: longstanding, personalised exercise therapy for 52 weeks. Active treatment comprised exercises (aerobic, muscle
strengthening, flexibility/joint range of motion and functional/ neuromotor exercises), patient education and the promotion of physical activity, including the provision of a simple waist pedometer. Control group received usual care, with the content and delivery determined by the treating clinician(s) and participants themselves.
Unable to blind participants due to intervention, might have some effect on patient-reported outcomes. Allocation concealment was not held during the study for all participants despite respectful efforts for concealment, outcome assessors became aware of the allocation to some amount. This might be considered inevitable in long studies, and probably has only minor effect on patient-reported outcomes. Control group might have participated in physiotherapy, as this was not denied.
Bilberg
et al. 2024 «Bilberg A, Mannerkorpi K, Borjesson M, et al. High...»7
Patients fulfilling the American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) 1987/2010 criteria for RA,23 24 with disease duration >1 year, aged 20–60 years, stable treatment on antirheumatic drugs for the past 3 months, and low-to-moderate disease activity (DAS28 <5.1) were eligible for inclusion. DAS28 <5.1 was chosen as upper limit for inclusion for safety considerations. Exclusion criteria were symptoms of CVD, other comorbidities, physical disabilities and pregnancy precluding participation in high-intensity exercise, engagement in regular cardiorespiratory exercise on high intensity level (>1 hour/week for the past 6 months), inability to understand and speak Swedish.
Interventions: Exercise program consisted of high intensity interval training two times/week and muscle strength exercise two times/week (supervised) and non-supervised aerobic exercise one/week. Control group received individual information of the general health recommendations for physical activity, with encouragement to be physically active on moderate intensity level ≥150 min/week. A home exercise programme was provided, and verbal and written instructions were given. Duration of the interventions: 12 weeks
Unable to blind participants due to intervention, but this has no relevant effect on the objective outcomes used. No biases detected.
Clinically meaningful means HAQ DI change >0.22, which is a frequently used Minimal clinically important difference (MCID) for HAQ-DI in people with rheumatoid arthritis (Behrens et al. 2019). However, MCID may be as low as 0.07 in people with arthralgia (Claasen et al. 2025), whereas discrimination from random long-term variations in patients on stable therapy may require a MCID as high as 0.68 (Claasen et al. 2025).
The Minimal Important Difference for the PSC1 NRS (on a scale from 0 to 10) ranged from 1.3 (small change) to 2.3 (medium change) to 2.7 (large change) in people with musculoskeletal disorders (Abbott 2014).
Minimal important difference in VAS is defined as -1,5 = small, -3 = medium and -3,5 = large (Abbott et al. 2014)
Summary of the risk of bias Evidence is based on three systematic reviews and meta-analysis, and four RCT studies, one large (n=217), two medium-sized (n≈80) and one small (n=20). The risk of bias in the reviews is moderate to high, whereas the risk of bias in the RCT studies is low. The grading of evidence is done individually for every four outcomes.

Results

Table 3. Outcome 1: Function
Reference Number of studies and number of participants (intervention (I) / control (C)) Follow-up (F) Relative effect (95% CI)
(results after intervention)
Level of evidence: moderate
The quality of evidence is downgraded due to (study limitations, inconsistency, imprecision).
I= intervention; C=comparison; CI=confidence interval; HAQ DI=Health Assessment Questionnaire disability index; HAQ = Health Assessment Questionnaire; MD = Maen Difference; WMD = Weighted Maen Difference (WMD); OT = occupational therapy; PSC1 NRS = Patient-Specific Complaints Numerical Rating Scale
Ye
et al. 2022 «Ye H, Weng H, Xu Y, et al. Effectiveness and safet...»1
11 RCT studies
n=735
I (aerobic exercise) 378 participants
C (usual care)
357 participants
None (assessments were performed immediately at the end of the training interventions, with no follow-up measurements). Exercise had a clinically important effect on function HAQ DI MD -0.25 [-0.38. -0.11]
No significant difference between
long-term and short-term interventions
Wen
et al. 2021 «Wen Z, Chai Y. Effectiveness of resistance exercis...»2
13 RCT studies
n=745
I (strength and rehab exercises)
380 participants
Control (usual care)
365 participants
None (assessments were performed immediately at the end of the training interventions, with no follow-up measurements). No statistical difference between groups (HAQ WMD -0.10 [-0.26, 0.06]
Sobue
et al. 2021 «Sobue Y, Kojima T, Ito H, et al. Does exercise the...»3
5 RCT studies
n=347
I (exercise)
170 participants
C (usual care)
177 participants
F: n/a Exercise had a clinically important effect on function HAQ DI MD -0.35 [-0,60, -0.10]
Cerasola
et al. 2023 «Cerasola D, Argano C, Chiovaro V, et al. Physical ...»5
1 RCT (single study)
n=160
I (OT + comb. exer.)
80 participants
C (education)
80 participants
None Exercise had a clinically important effect on function HAQ MD 2.05 ± 0.83
Tauwen
et al. 2024 «Teuwen MMH, van Weely SFE, Vliet Vlieland TPM, et ...»6
1 RCT (single study)
n=202
I (comb. exercise)
104 participants
C (education)
98 participants
None Exercise had a large effect on function compared to education alone (PSC1 NRS MD -1.7 [-2.4, -1.0]; ES 0.7). Similar results in secondary outcome measures.
Table 4. Outcome 2: Disease activity
Reference Number of studies and number of participants (intervention (I) / control (C)) Follow-up (F) Relative effect (95% CI)
(results after intervention)
Level of evidence: low
The quality of evidence is downgraded due to (study limitations, inconsistency, imprecision).
I= intervention; C=comparison; CI=confidence interval; MD = Mean Difference; SMD = Standardized Mean Difference; DAS28 = Disease Activity Score in 28 joints;CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; TJC = tender joint count; SJC = swollen joint count; RAI = Ritchie Articular Index

Ye
et al. 2022 «Ye H, Weng H, Xu Y, et al. Effectiveness and safet...»1
DAS28
8 RCT studies
I (aerobic exercise) 289 participants
C (usual care)
284 participants
CRP
5 RCT studies
I (aerobic exercise) 149 participants
C (usual care)
149 participants
ESR
5 RCT studies
I (aerobic exercise) 157 participants
C (usual care)
148 participants
n/a No statistically significant difference in disease activity between groups, when measured with DAS28:
MD -0.55 [-1.12, 0.01] or CRP:
MD -1.08 [-2.20,0.05] or ESR:
SMD -0.76 [-1.67, 0.14]
Subgroup analysis showed
that long-term aerobic
exercise significantly decreased CRP levels:
MD = -2.28 [-3.24, -1.33]
Wen
et al. 2021 «Wen Z, Chai Y. Effectiveness of resistance exercis...»2
8 RCT studies (DAS28)
6 RCT studies (ESR)
I (strength and rehab exercises)
DAS28: 252 participants
ESR: 178
Control (usual care)
DAS28241 participants
ESR 158 participants
n/a Exercise had a moderate effect on decreased disease activity when measured with DAS28: SMD -0.69 [-1.26, -0.11]. and a large effect when measured with ESR: SMD -0.86 [-1.65,
-0.07]
Sobue
et al. 2021 «Sobue Y, Kojima T, Ito H, et al. Does exercise the...»3
3 RCT studies
I (exercise)
79 participants
C (usual care)
88 participants
n/a No statistically significant difference between groups on disease activity: MD DAS28
-0.52 [-1.25, 0.21]
Andonian
et al. 2023 «Andonian BJ, Ross LM, Sudnick AM, et al. Effect of...»4
1 RCT (single study)
I (exercise)
12 participants
C (education)
12 participants
none Statistically significant disease activity reduction in the exercise group compared to control group in DAS28-CPR
but not in DAS28-ESR. No difference between groups in other outcomes (TJC, SJC, RAI, hs-CRP, ESR)
Cerasola
et al. 2023 «Cerasola D, Argano C, Chiovaro V, et al. Physical ...»5
1 RCT (single study)
I (OT + comb. exer.)
80 participants
C (education)
80 participants
none Statistically significant disease activity reduction in the exercise group compared to control group: DAS28-ESR MD
-1.95±0.84 vs. -0.37±1.69 and DAS28-CRP MD -2.0±0.88 vs.
-0.7±1.69
Bilberg
et al. 2024 «Bilberg A, Mannerkorpi K, Borjesson M, et al. High...»7
1 RCT (single study)
I (comb. exercise)
44 participants
C (education)
43 participants
none No statistically significant difference between groups (DAS28-ESR, ESR, CRP)
Table 5. Outcome 3: Pain
Reference Number of studies and number of participants (intervention (I) / control (C)) Follow-up (F) Relative effect (95% CI)
(results after intervention)
Level of evidence: very low
The quality of evidence is downgraded due to (study limitations, inconsistency and imprecision.
I= intervention; C=comparison; CI=confidence interval; MD = Mean Difference; SMD = Standardized Mean Difference; VAS = Visual Analogue Scale;
Ye
et al. 2022 «Ye H, Weng H, Xu Y, et al. Effectiveness and safet...»1
4 RCT studies
I (aerobic exercise) 128 participants
C (usual care)
119 participants
D: 2-96 wk (subgroups long term > 16wk and short term ≤ 16 wk)
F: n/a
Exercise had a small effect on pain (SMD -0.46 [-0.90, -0.01]
Wen
et al. 2021 «Wen Z, Chai Y. Effectiveness of resistance exercis...»2
6 RCT studies
I (strength and rehab exercises)
159 participants
Control (usual care)
159 participants
D: 4-104 weeks
F: n/a
No statistical difference between groups in pain scores when measured with VAS SMD -0.61[-1.49, 0.27]
Sobue
et al. 2021 «Sobue Y, Kojima T, Ito H, et al. Does exercise the...»3
3 RCT studies
I (exercise)
123 participants
C (usual care)
121 participants
D: 4-16 weeks
F: n/a
Exercise had a small effect on pain when measured with VAS MD -2.04 [-3.77, -0.32]
Bilberg
et al. 2024 «Bilberg A, Mannerkorpi K, Borjesson M, et al. High...»7
1 RCT (single study)
I (comb. exercise)
44 participants
C (education)
43 participants
D: 12 weeks
F: none
No statistical difference between groups in pain scores when measured with VAS
MD -4.0 [-13.07, 5.06]

Notes: Minimal important difference in VAS is defined as -1,5 = small, -3 = medium and -3,5 = large (Abbott et al. 2014 «Abbott JH, Schmitt J. Minimum important difference...»8)

Table 6. Outcome 4: Quality of life
Reference Number of studies and number of participants (intervention (I) / control (C)) Follow-up (F) Relative effect (95% CI)
(results after intervention)
Level of evidence: low
The quality of evidence is downgraded due to (study limitations, inconsistency, imprecision).
I= intervention; C=comparison; CI=confidence interval; MD = Mean Difference; SMD = Standardized Mean Difference; VAS = Visual Analogue Scale; RAQoL = Rheumatoid Arthritis Quality of Life; SF-36 = 36-Item Short-Form Health Survey
Sobue
et al. 2021 «Sobue Y, Kojima T, Ito H, et al. Does exercise the...»3
2 RCT studies
I (exercise)
78 participants
C (usual care)
84 participants
n/a Exercise had a beneficial effect on 6/8 categories of the SF36:
Functional skills
MD 21.39 [13.71, 29.07]
Pain
MD 13.21 [7.36, 19.05]
General health
MD 13.75 [5.77, 21.73]
Vitality
MD 7.51 [1.41, 13.62]
Social aspects
MD 11.04 [0.64, 21.43]
Mental health
MD 10.34 [2.11, 18.57]
and no difference between groups in 2/8 categories:
Physical aspects
MD 22.26 [-2.40, 46.92]
Emotional aspects
MD 15.25 [-3.18, 33.68]
Tauwen
et al. 2024 «Teuwen MMH, van Weely SFE, Vliet Vlieland TPM, et ...»6
1 RCT (single study)
I (comb. exercise)
104 participants
C (education)
98 participants
F: none Exercise improved quality of life when measured with RAQoL:
MD -2.03 [-3.38, -0.69]
and SF-36 PCS:
MD 3.83 [1.49, 6.17]
There were no difference between groups when measured with SF-36 MCS: MD 2.54 [-0.47,5.54]

References

  1. Ye H, Weng H, Xu Y, et al. Effectiveness and safety of aerobic exercise for rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. BMC Sports Sci Med Rehabil 2022;14(1):17 «PMID: 35123568»PubMed
  2. Wen Z, Chai Y. Effectiveness of resistance exercises in the treatment of rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) 2021;100(13):e25019 «PMID: 33787585»PubMed
  3. Sobue Y, Kojima T, Ito H, et al. Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthritis. Mod Rheumatol 2022;32(1):96-104 «PMID: 33565350»PubMed
  4. Andonian BJ, Ross LM, Sudnick AM, et al. Effect of Remotely Supervised Weight Loss and Exercise Training Versus Lifestyle Counseling on Cardiovascular Risk and Clinical Outcomes in Older Adults With Rheumatoid Arthritis: A Randomized Controlled Trial. ACR Open Rheumatol 2024;6(3):124-136 «PMID: 38126260»PubMed
  5. Cerasola D, Argano C, Chiovaro V, et al. Physical Exercise and Occupational Therapy at Home to Improve the Quality of Life in Subjects Affected by Rheumatoid Arthritis: A Randomized Controlled Trial. Healthcare (Basel) 2023;11(15): «PMID: 37570365»PubMed
  6. Teuwen MMH, van Weely SFE, Vliet Vlieland TPM, et al. Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial. Ann Rheum Dis 2024;83(4):437-445 «PMID: 38171602»PubMed
  7. Bilberg A, Mannerkorpi K, Borjesson M, et al. High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial. Br J Sports Med 2024;58(23):1409-1418 «PMID: 39179363»PubMed
  8. Abbott JH, Schmitt J. Minimum important differences for the patient-specific functional scale, 4 region-specific outcome measures, and the numeric pain rating scale. J Orthop Sports Phys Ther 2014;44(8):560-4 «PMID: 24828475»PubMed
  9. Behrens F, Koehm M, Schwaneck EC, et al. Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis. BMC Rheumatol 2019;3():51 «PMID: 31867564»PubMed
  10. Boniface G, Gandhi V, Norris M, et al. A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis. Rheumatology (Oxford) 2020;59(11):3147-3157 «PMID: 32780816»PubMed
  11. Claassen S, van Steenbergen HW, van der Helm-van Mil AHM. Assessment of the minimal clinically important difference for the Health Assessment Questionnaire Disability Index in patients with arthralgia at risk for progression to rheumatoid arthritis. RMD Open 2025;11(3): «PMID: 40983396»PubMed